Meeting the 2012 QIP (Quality Incentive Program) Clinical Measures: Strategies for Dialysis Centers

American Journal of Kidney Diseases

Volumn 60, Issue 5 SUPPL. 1, 2012, Pages

  Fishbane, Steven ^a   Hazzan, Azzour ^a  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

anemia; clinical measures; hemodialysis adequacy; Quality Incentive Program (QIP); US Centers for Medicare Medicaid Services (CMS); vascular access type

Indexed keywords

CANNULATION; CONFERENCE PAPER; DIALYSIS; FINANCIAL MANAGEMENT; HEALTH PROGRAM; HEALTH SURVEY; HEMODIALYSIS; HUMAN; MEASUREMENT; PATIENT EDUCATION; PATIENT MONITORING; PATIENT SATISFACTION; QUALITY INCENTIVE PROGRAM; VASCULAR ACCESS;

CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); HUMANS; KIDNEY FAILURE, CHRONIC; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; PATIENT SAFETY; PATIENT SATISFACTION; QUALITY OF HEALTH CARE; RENAL DIALYSIS; UNITED STATES;

EID: 84867382266     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.07.002     Document Type: Conference Paper

References (56)

1. Centers for Medicare & Medicaid Services, HHS Medicare program; end-stage renal disease prospective payment system and quality incentive program; ambulance fee schedule; durable medical equipment; and competitive acquisition of certain durable medical equipment prosthetics, orthotics and supplies Final rule Fed Regist 76 218 2011 70228 70316
2. Centers for Medicare & Medicaid Services Special Open Door Forum: end-stage renal disease Quality Incentive Program Final Rule: payment years 2013 and 2014 Presented on Thursday, February 2, 2012 https://cms.gov/Medicare/End- Stage-Renal-Disease/ESRDQualityImproveInit/Downloads/13-14QIPODF020212.pdf Accessed July 3, 2012
3. S. Fishbane, I. Miller, H. Danko, N. Masani The QIP: will it improve dialysis care? An overview Nephrol News Issues 26 1 2012 22 24 26
4. S. Fishbane, I. Miller, J.D. Wagner, N.N. Masani Changes to the end-stage renal disease Quality Incentive Program Kidney Int 81 12 2012 1167 1171
5. US Food and Drug Administration Modified dosing recommendations to improve the safe use of erythropoiesis-stimulating agents (ESAs) in chronic kidney disease FDA Drug Safety Communication 6/24/2011 http://www.fda.gov/drugs/ drugsafety/ucm259639.htm Accessed July 3, 2012
6. M.A. Pfeffer, E.A. Burdmann, C.-Y. Chen TREAT Investigators A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 21 2009 2019 2032
7. A. Besarab, W.K. Bolton, J.K. Browne The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin N Engl J Med 339 9 1998 584 590
8. A.K. Singh, L. Szczech, K.L. Tang CHOIR Investigators Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 20 2006 2085 2098
9. S. Fishbane, J.S. Berns Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin Kidney Int 68 3 2005 1337 1343
10. S. Fishbane, J.S. Berns Evidence and implications of haemoglobin cycling in anaemia management Nephrol Dial Transplant 22 8 2007 2129 2132
11. A.K. Singh, E. Milford, S. Fishbane, S.R. Keithi-Reddy Managing anemia in dialysis patients: hemoglobin cycling and overshoot Kidney Int 74 5 2008 679 683
12. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease Am J Kidney Dis 47 5 suppl 3 2006 S11 S145
13. National Kidney Foundation KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 update of hemoglobin target Am J Kidney Dis 50 3 2007 471 530
14. S. Fishbane, K. Larson, S. VanBuskirk Stabilizing hemoglobin levels: what's new in IV iron and anemia management? Nephrol Nurs J 35 5 2008 493 502
15. A. Besarab, N. Amin, M. Ahsan Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients J Am Soc Nephrol 11 3 2000 530 538
16. L. Bolaños, P. Castro, T.G. Falcón, R. Mouzo, J.M. Varela Continuous intravenous sodium ferric gluconate improves efficacy in the maintenance phase of EPOrHu administration in hemodialysis patients Am J Nephrol 22 1 2002 67 72
17. K. Kalantar-Zadeh, G.R. Aronoff Hemoglobin variability in anemia of chronic kidney disease J Am Soc Nephrol 20 3 2009 479 487
18. S. Fishbane, P.J. Dutka Dialysis Center Dialogues: the ESRD QIP final rule Presentation given January and February 2012. Live Web conference www.dialysiscme.com Accessed May 7, 2012
19. N. Tangri, H. Tighiouart, K.B. Meyer, D.C. Miskulin Both patient and facility contribute to achieving the Centers for Medicare and Medicaid Services' pay-for-performance target for dialysis adequacy J Am Soc Nephrol 22 12 2011 2296 2302
20. A.R. Sehgal, J.B. Leon, L.A. Siminoff, M.E. Singer, L.M. Bunosky, R.D. Cebul Improving the quality of hemodialysis treatment: a community-based randomized controlled trial to overcome patient-specific barriers JAMA 287 15 2002 1961 1967
21. A.R. Sehgal, R.J. Snow, M.E. Singer Barriers to adequate delivery of hemodialysis Am J Kidney Dis 31 4 1998 593 601
22. P.M. Palevsky, M.S. Washington, J.A. Stevenson Barriers to the delivery of adequate hemodialysis in ESRD Network 4 Adv Ren Replace Ther 7 4 suppl 1 2000 S11 S20
23. Tentori F, Zhang J, Li Y, et al. Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) [published online ahead of print March 19, 2012]. Nephrol Dial Transplant. doi:10.1093/ndt/gfs021.
24. G. Eknoyan, G.J. Beck, A.K. Cheung Hemodialysis (HEMO) Study Group Effect of dialysis dose and membrane flux in maintenance hemodialysis N Engl J Med 347 25 2002 2010 2019
25. G.M. Chertow, N.W. Levin, G.J. Beck FHN Trial Group In-center hemodialysis six times per week versus three times per week N Engl J Med 363 24 2010 2287 2300
26. E. Lacson Jr, S.M. Brunelli Hemodialysis treatment time: a fresh perspective Clin J Am Soc Nephrol 6 10 2011 2522 2530
27. R. Saran, J.L. Bragg-Gresham, N.W. Levin Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS Kidney Int 69 7 2006 1222 1228
28. E. Lacson Jr, W. Wang, K. Lester, N. Ofsthun, J.M. Lazarus, R.M. Hakim Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program Clin J Am Soc Nephrol 5 2 2010 220 226
29. J.E. Miller, C.P. Kovesdy, A.R. Nissenson Association of hemodialysis treatment time and dose with mortality and the role of race and sex Am J Kidney Dis 55 1 2010 100 112
30. S.M. Brunelli, G.M. Chertow, E.D. Ankers, E.G. Lowrie, R. Thadhani Shorter dialysis times are associated with higher mortality among incident hemodialysis patients Kidney Int 77 7 2010 630 636
31. R.A. Ward Do clinical outcomes in chronic hemodialysis depend on the choice of a dialyzer? Semin Dial 24 1 2011 65 71
32. R.K. Dhingra, E.W. Young, T.E. Hulbert-Shearon, S.F. Leavey, F.K. Port Type of vascular access and mortality in US hemodialysis patients Kidney Int 60 4 2001 1443 1451
33. S. Pastan, J.M. Soucie, W.M. McClellan Vascular access and increased risk of death among hemodialysis patients Kidney Int 62 2 2002 620 626
34. J.L. Xue, D. Dahl, J.P. Ebben, A.J. Collins The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients Am J Kidney Dis 42 5 2003 1013 1019
35. K.R. Polkinghorne, S.P. McDonald, R.C. Atkins, P.G. Kerr Vascular access and all-cause mortality: a propensity score analysis J Am Soc Nephrol 15 2 2004 477 486
36. B.C. Astor, J.A. Eustace, N.R. Powe, M.J. Klag, N.E. Fink, J. Coresh CHOICE Study Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study J Am Soc Nephrol 16 5 2005 1449 1455
37. R.L. Pisoni, C.J. Arrington, J.M. Albert Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis Am J Kidney Dis 53 3 2009 475 491
38. D.H. Chand, B.W. Teo, R.A. Fatica, M. Brier Medical Review Board of The Renal Network, Inc Influence of vascular access type on outcome measures in patients on maintenance hemodialysis Nephron Clin Pract 108 2 2008 c91 c98
39. Fistula First Breakthrough Initiative National AV fistula rate http://www.fistulafirst.org/ Accessed April 12, 2012
40. J.R. Lynch, S. Mohan, W.M. McClellan Achieving the goal: results from the Fistula First Breakthrough Initiative Curr Opin Nephrol Hypertens 20 6 2011 583 592
41. W. Xi, L. Harwood, M.J. Diamant Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making Nephrol Dial Transplant 26 10 2011 3302 3308
42. R.R. Quinn, D.L. Lamping, C.E. Lok The Vascular Access Questionnaire: assessing patient-reported views of vascular access J Vasc Access 9 2 2008 122 128
43. K.L. Cavanaugh, R.L. Wingard, R.M. Hakim, T.A. Elasy, T.A. Ikizler Patient dialysis knowledge is associated with permanent arteriovenous access use in chronic hemodialysis Clin J Am Soc Nephrol 4 5 2009 950 956
44. L.K. Ball Improving arteriovenous fistula cannulation skills Nephrol Nurs J 32 6 2005 611 617
45. S. Mott, H. Moore Using "tandem hand" technique to facilitate self-cannulation in hemodialysis Nephrol Nurs J 36 3 2009 313 316 325
46. Fistula First Breakthrough Initiative Cannulation of new fistula policy and procedure Updated July 2011 http://www.fistulafirst.org Accessed April 17, 2012
47. A. Hashmi, M.Q. Cheema, A.H. Moss Hemodialysis patients' experience with and attitudes toward the buttonhole technique for arteriovenous fistula cannulation Clin Nephrol 74 5 2010 346 350
48. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access Am J Kidney Dis 48 suppl 1 2006 S1 S322
49. L.K. Ball The buttonhole technique for arteriovenous fistula cannulation Nephrol Nurs J 33 3 2006 299 304
50. A.M. Verhallen, M.P. Kooistra, B.C. van Jaarsveld Cannulating in haemodialysis: rope-ladder or buttonhole technique? Nephrol Dial Transplant 22 9 2007 2601 2604
51. Z.J. Twardowski, H. Kubara Different site versus constant sites of needle insertion into arteriovenous fistulas for treatment by repeated dialysis Dial Transplant 8 1979 978 980
52. M.M. van Loon, T. Goovaerts, A.G. Kessels, F.M. van der Sande, J.H. Tordoir Buttonhole needling of haemodialysis arteriovenous fistulae results in less complications and interventions compared to the rope-ladder technique Nephrol Dial Transplant 25 1 2010 225 230
53. S. Doss, B. Schiller, J. Moran Buttonhole cannulation - an unexpected outcome Nephrol Nurs J 35 4 2008 417 419
54. R.M. Marticorena, J. Hunter, S. Macleod The salvage of aneurysmal fistulae utilizing a modified buttonhole cannulation technique and multiple cannulators Hemodial Int 10 2 2006 193 200
55. L.K. Ball The buttonhole technique: strategies to reduce infections Nephrol Nurs J 37 5 2010 473 477
56. Y.S. Spolter, S.L. Seliger, M. Zhan, V.D. Hsu, L.D. Walker, J.C. Fink The relationship between dialysis performance measures: adequacy and anemia management Am J Kidney Dis 50 5 2007 774 781